CXCL12 and cancer: This potent molecule is not only chemotactic for the bone marrow derived haematopoietic progenitor cells shown to be critical to the development of the premetastatic niche [16], but also for cancer cells that often express the cognate receptor for SDF-1, CXCR4 [34].